Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B.
about
The Comparative Efficacy and Safety of Entecavir and Lamivudine in Patients with HBV-Associated Acute-on-Chronic Liver Failure: A Systematic Review and Meta-AnalysisAdaptive immunity in the liverChronic Hepatitis B with Spontaneous Severe Acute ExacerbationThe Role of Oxidative Stress and Antioxidants in Liver DiseasesRestoring homeostasis of CD4⁺ T cells in hepatitis-B-virus-related liver fibrosisT Helper 17/Regulatory T Cell Balance and Experimental Models of Peritoneal Dialysis-Induced DamageReview article: chemokines as orchestrators of autoimmune hepatitis and potential therapeutic targetsThe L60V Variation in Hepatitis B Virus Core Protein Elicits New Epitope-Specific Cytotoxic T Lymphocytes and Enhances Viral ReplicationHepatitis C virus promotes T-helper (Th)17 responses through thymic stromal lymphopoietin production by infected hepatocytes.Primary biliary cirrhosis-associated hepatocellular carcinoma in Chinese patients: incidence and risk factorsJoint modeling of HIV data in multicenter observational studies: A comparison among different approaches.Decreased ratio of Treg cells to Th17 cells correlates with HBV DNA suppression in chronic hepatitis B patients undergoing entecavir treatmentHyper-activated pro-inflammatory CD16 monocytes correlate with the severity of liver injury and fibrosis in patients with chronic hepatitis B.Activated IL-23/IL-17 pathway closely correlates with increased Foxp3 expression in livers of chronic hepatitis B patients.Interleukin-17 contributes to the pathogenesis of autoimmune hepatitis through inducing hepatic interleukin-6 expression.Changes in circulating Foxp3(+) regulatory T cells and interleukin-17-producing T helper cells during HBV-related acute-on-chronic liver failure.The role of chemokines in the recruitment of lymphocytes to the liver.Licensing virus-specific T cells to secrete the neutrophil attracting chemokine CXCL-8 during hepatitis B virus infectionDifferential modulation by IL-17A of Cholangitis versus Colitis in IL-2Rα deleted mice.Changes of Treg and Th17 cells balance in the development of acute and chronic hepatitis B virus infection.IL-17A enhances the expression of profibrotic genes through upregulation of the TGF-β receptor on hepatic stellate cells in a JNK-dependent manner.Polyfunctional type-1, -2, and -17 CD8⁺ T cell responses to apoptotic self-antigens correlate with the chronic evolution of hepatitis C virus infection.Significance of the balance between regulatory T (Treg) and T helper 17 (Th17) cells during hepatitis B virus related liver fibrosisA fusion DNA vaccine encoding middle version of HBV envelope protein fused to interleukin-21 did not enhance HBV-specific immune response in mice.Elevated pretherapy serum IL17 in primary hepatocellular carcinoma patients correlate to increased risk of early recurrence after curative hepatectomy.Highest frequencies of interleukin-22-producing T helper cells in alcoholic hepatitis patients with a favourable short-term course.Galectin-9 and IL-21 mediate cross-regulation between Th17 and Treg cells during acute hepatitis C.Characterization of HCV-specific CD4+Th17 immunity in recurrent hepatitis C-induced liver allograft fibrosis.Hepatitis B virus induces IL-23 production in antigen presenting cells and causes liver damage via the IL-23/IL-17 axis.Induction of regulatory T cells by high-dose gp96 suppresses murine liver immune hyperactivation.Th17 down-regulation is involved in reduced progression of schistosomiasis fibrosis in ICOSL KO mice.Pathological role of interleukin-17 in poly I:C-induced hepatitis.Elevated IL-6 receptor expression on CD4+ T cells contributes to the increased Th17 responses in patients with chronic hepatitis B.In vivo consequences of liver-specific interleukin-22 expression in mice: Implications for human liver disease progression.Protective role of α2HS-glycoprotein in HBV-associated liver failure.Prevalence and clinical relevance of T-helper cells, Th17 and Th1, in hepatitis B virus-related hepatocellular carcinomaThe balance between intrahepatic IL-17(+) T cells and Foxp3(+) regulatory T cells plays an important role in HBV-related end-stage liver disease.Risk of hepatitis B virus reactivation in rheumatoid arthritis patients undergoing biologic treatment: Extending perspective from old to newer drugs.A proinflammatory role for interleukin-22 in the immune response to hepatitis B virus.The Transforming Growth Factor β1/Interleukin-31 Pathway Is Upregulated in Patients with Hepatitis B Virus-Related Acute-on-Chronic Liver Failure and Is Associated with Disease Severity and Survival
P2860
Q26752443-D73B213E-CCA4-4101-983E-93C6EEEBAD2AQ26753195-065D4174-DDB5-4D93-91EE-9916DCD0B8A2Q26772036-B82B31AF-7338-48D3-8EF5-D9F571914D7FQ26779146-467BB2F0-B707-4A13-8984-5CDF46BDC4F0Q26782048-E1DE5F93-9488-4386-8B9E-72CB73106C9BQ27002418-FFA43093-6132-4805-97AF-9A9DA6B08CDBQ27025680-4AD30468-CFCD-46C5-8594-1890AA28B1F1Q27678163-184E2B74-87F0-47CC-AEB3-1D08583992B0Q30414014-E1CD7A00-159E-4432-846C-70ACC607D4DCQ30415672-514293BC-33AB-4024-8314-7FCA11230977Q30786463-2A25E3E3-BDC2-4D02-A7C5-DFD828250D18Q33747793-7AF5105F-E553-4825-B09D-695C968D7105Q33842114-8A924F47-AEA3-49CD-BD60-4CA5AB76CA11Q33871750-B3B60B3D-895D-4CF9-A2E9-8A9D8233ED6AQ33883569-84F1CB2B-2FAF-4034-A53C-BA6955818795Q33887028-62ACE857-47A8-4FD2-A5D0-5AA3789D1BB6Q33906565-1CE1EF89-EFFF-45E4-9720-D75C4703B8D9Q34005464-E0AD78FB-DF85-4DEE-9483-725CFDF4F459Q34061724-C32E839E-F44A-4897-829E-5DABCC746BE9Q34252890-2CD1163B-C38E-4318-BD3F-8DC4C20D24E4Q34289189-4FD63B33-C18C-40DD-A86E-160FEC70B1C9Q34318203-770E3643-0531-4175-B293-9FA681223056Q34321305-FB5671D9-DDD3-4396-A99F-BFB042D8CA78Q34439869-ED7E0077-926E-4665-9147-9E07D50DAC3EQ34506935-62595AD1-F701-47D2-9D8B-09B9EC7B3A3EQ34571578-6442A8E4-DEF0-4DB9-A26C-09915AE96A3BQ34789276-EDC2C2C4-E0D3-47EA-8C92-33673B17C98CQ34795394-FC2B8CF0-8631-46C5-8AE7-6312FD415E29Q34795426-85A12816-C59E-45F2-80FD-3763015911A4Q34852383-49B8E0F4-691B-4E0A-BA7E-82DBAA8F7991Q34973340-6BAB8041-2ECB-425F-8C03-7B6AF5869CFFQ34998903-2614B0BA-9854-4B25-A05E-FAF6AF9BA834Q35054759-7AD09399-C99C-4637-92AB-23DA3816D032Q35074604-55CDE499-1579-49B6-993C-C4E7AF0DBC69Q35091813-1967AF03-70C2-44F4-ABA2-7CD866F305B7Q35175019-F688482D-ECBD-4758-A349-8FE4B9A39540Q35221884-046F2A00-1A0E-4290-BE7F-80CB2E5ECF77Q35237316-67A3262D-594E-40A4-B7F3-BA11816C6846Q35420938-2F11DDEB-1E36-44D4-A9D0-112F5C193C5CQ35548023-0014740B-E242-4203-B10E-0E7A86CEE09B
P2860
Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Interleukin-17-producing CD4
@nl
Interleukin-17-producing CD4(+ ...... ents with chronic hepatitis B.
@en
type
label
Interleukin-17-producing CD4
@nl
Interleukin-17-producing CD4(+ ...... ents with chronic hepatitis B.
@en
prefLabel
Interleukin-17-producing CD4
@nl
Interleukin-17-producing CD4(+ ...... ents with chronic hepatitis B.
@en
P2093
P2860
P356
P1433
P1476
Interleukin-17-producing CD4(+ ...... ents with chronic hepatitis B.
@en
P2093
Fu-Sheng Wang
Hui-Fen Wang
Ji-Yuan Zhang
Jun-Liang Fu
Ruo-Nan Xu
Zheng Zhang
P2860
P356
10.1002/HEP.23273
P407
P577
2010-01-01T00:00:00Z